UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
CNS drugs, ISSN 1172-7047, 12/2012, Volume 26, Issue 12, p. 1073
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 11/2020, Volume 142, Issue Suppl_3 Suppl 3, pp. A13442 - A13442
Journal Article
Neurology, ISSN 0028-3878, 12/2016, Volume 87, Issue 24, pp. 2585 - 2593
Journal Article
Bioorganic & medicinal chemistry letters, ISSN 0960-894X, 06/2011, Volume 21, Issue 12, p. 3771
Journal Article
Pneumologe, ISSN 1613-5636, 09/2013, Volume 10, Issue 5, p. 341
Journal Article
Journal of the neurological sciences, ISSN 0022-510X, 10/2017, Volume 381, pp. 294 - 295
Journal Article
Drug and alcohol dependence, ISSN 0376-8716, 2016, Volume 171, pp. e51 - e51
Journal Article
Diabetes care, ISSN 0149-5992, 2008, Volume 31, Issue 2, pp. S255 - 261
Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Aldehyde Reductase - antagonists & inhibitors | Diabetic Neuropathies - prevention & control | Humans | Polyneuropathies - epidemiology | Polyneuropathies - prevention & control | Analgesics, Opioid - therapeutic use | Polyneuropathies - drug therapy | Clinical Trials as Topic | Diabetic Neuropathies - drug therapy | Imidazolidines - therapeutic use | Polyneuropathies - physiopathology | Enzyme Inhibitors - therapeutic use | Incidence | Inositol - blood | Diabetic Neuropathies - epidemiology | Sodium Channel Blockers - therapeutic use | Sodium-Potassium-Exchanging ATPase - blood | Diabetic Neuropathies - physiopathology | Medical research | Anticonvulsants | Care and treatment | Pain | Medicine, Experimental | Diabetes | Health aspects | Risk factors | Studies | Side effects | Hospitals | Mortality | Diabetic neuropathy | Clinical medicine | Drug therapy | Foot diseases | Drug use | Quality of life | Fibers | Index Medicus
Journal Article
Naunyn-Schmiedeberg's archives of pharmacology, ISSN 0028-1298, 01/2008, Volume 376, Issue 5, p. 301
Journal Article
Clinical neurophysiology, ISSN 1388-2457, 09/2006, Volume 117, pp. 204 - 205
Journal Article
Psychopharmacology update, ISSN 1068-5308, 12/2013, Volume 24, Issue 12, p. 8
Journal Article
Journal of the neurological sciences, ISSN 0022-510X, 2015, Volume 357, pp. e282 - e283
Journal Article
CNS drugs, ISSN 1172-7047, 2008, Volume 22, Issue 5, pp. 417 - 422
NMDA receptor antagonists, therapeutic use | GABA receptor agonists, therapeutic use | Neuropathic pain, treatment | Local anaesthetics, therapeutic use | Antiepileptic drugs, therapeutic use | Antidepressants, therapeutic use | Diabetic nephropathies, treatment | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Antidepressive Agents - therapeutic use | Animals | Neuralgia, Postherpetic - complications | Humans | Anticonvulsants - therapeutic use | Analgesics, Opioid - therapeutic use | Diabetic Neuropathies - drug therapy | Neuralgia, Postherpetic - drug therapy | Diabetic Neuropathies - complications | Topiramate | Gabapentin | Desipramine | Capsaicin | Oxycodone | Clinical trials | Serotonin uptake inhibitors | Nervous system | Diabetic neuropathy | Infections | Dextromethorphan | Neuropathy | Antiepileptic agents | Peripheral neuropathy | Oxcarbazepine | Imipramine | Pain | Analgesics | Antidepressants | Tramadol | Opioids | Drug therapy | Drug dosages | Amitriptyline | Narcotics | Diabetes mellitus | Duloxetine | Valproic acid | Carbamazepine | Quality of life | Studies | Norepinephrine | Diabetes | Neuralgia | Lidocaine | Phenytoin | Lamotrigine
Journal Article
Ultrasound in obstetrics & gynecology, ISSN 0960-7692, 10/2020, Volume 56, Issue S1, pp. 361 - 361
Journal Article
JAMA neurology, ISSN 2168-6149, 01/2019, Volume 76, Issue 1, pp. 28 - 34
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Analgesics - pharmacology | Pregabalin - administration & dosage | Pregabalin - adverse effects | Gabapentin - administration & dosage | Chronic Pain - drug therapy | Double-Blind Method | Humans | Middle Aged | Pregabalin - pharmacology | Analgesics - administration & dosage | Male | Sciatica - drug therapy | Cross-Over Studies | Gabapentin - adverse effects | Adult | Female | Aged | Outcome Assessment, Health Care | Analgesics - adverse effects | Gabapentin - pharmacology | Back pain | Pain | Gabapentin | Pain management | Clinical trials | Adults | Drug therapy | Clinical outcomes | Sciatica
Journal Article
Journal of veterinary internal medicine, ISSN 0891-6640, 11/2018, Volume 32, Issue 6, pp. 1996 - 2002
compounded | pain | feline | transdermal | Life Sciences & Biomedicine | Veterinary Sciences | Science & Technology | Gabapentin - administration & dosage | Injections, Intravenous - veterinary | Animals | Cats - metabolism | Gabapentin - blood | Analgesics - administration & dosage | Analgesics - blood | Half-Life | Female | Male | Analgesics - pharmacokinetics | Gabapentin - pharmacokinetics | Cats | Care and treatment | Pain | Gabapentin | Analysis | Dosage and administration | Liquid chromatography | Mass spectrometry | Chronic pain | Drugs | Mass spectroscopy | Pharmacology | Bioavailability | Pharmacokinetics | Drug dosages | Index Medicus | Standard | SMALL ANIMAL
Journal Article
Pain (Amsterdam), ISSN 0304-3959, 03/2014, Volume 155, Issue 3, p. 522
Journal Article
Cochrane library, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, pp. CD001415 - CD001415
gamma‐Aminobutyric Acid | Gabapentin | Epilepsy: drugs for broad populations | Epilepsy | Drugs for broad populations | Epilepsies, Partial | Randomized Controlled Trials as Topic | Antiepileptic drugs in broad populations with epilepsy | Drug Resistant Epilepsy | Neurology | Anticonvulsants | Drug‐resistant partial epilepsy | Add‐on antiepileptic drug therapies for people with drug‐resistant epilepsy | Intention to Treat Analysis | Child health | Cyclohexanecarboxylic Acids | Drug Therapy, Combination | Medicine General & Introductory Medical Sciences | Antiepileptic drugs | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclohexanecarboxylic Acids - therapeutic use | Gabapentin - administration & dosage | Epilepsies, Partial - drug therapy | Humans | Anticonvulsants - therapeutic use | Anticonvulsants - administration & dosage | Drug Resistant Epilepsy - drug therapy | Drug Therapy, Combination - methods | Anticonvulsants - adverse effects | Gabapentin - therapeutic use | Gabapentin - adverse effects | Adult | gamma-Aminobutyric Acid - therapeutic use | Child | Index Medicus
Journal Article
Trials, ISSN 1745-6215, 2019, Volume 20, Issue 1, pp. 49 - 49
Children | Gabapentin | Pharmacokinetics | Neuropathic pain | Chronic Pain - diagnosis | Gabapentin - administration & dosage | Age Factors | Humans | Child, Preschool | Infant | Male | Analgesics - pharmacokinetics | Gabapentin - pharmacokinetics | Pharmaceutical Solutions | Netherlands | Analgesics, Opioid - adverse effects | Multicenter Studies as Topic | Pain Management - adverse effects | Gabapentin - adverse effects | Female | Neuralgia - diagnosis | Neuralgia - physiopathology | Drug Therapy, Combination | Equivalence Trials as Topic | Child | Analgesics - adverse effects | Severity of Illness Index | Chronic Pain - drug therapy | Double-Blind Method | Administration, Oral | Pain Management - methods | Analgesics - administration & dosage | Treatment Outcome | Neuralgia - drug therapy | Analgesics, Opioid - administration & dosage | Adolescent | Chronic Pain - physiopathology | Pain Measurement | Morphine - administration & dosage | Morphine - adverse effects | Clinical Trials, Phase II as Topic | Care and treatment | Pain | Patient outcomes | Morphine | Pediatric research | Testing | Index Medicus
Journal Article
Movement disorders, ISSN 0885-3185, 01/2020, Volume 35, Issue 1, pp. 176 - 180
pregabalin | adverse drug reactions | parkinsonism | gabapentin | gabapentinoids | drug safety | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | gamma-Aminobutyric Acid - metabolism | Humans | Middle Aged | Pregabalin - metabolism | Pregabalin - pharmacology | Male | Gabapentin - metabolism | Parkinsonian Disorders - metabolism | Pharmaceutical Preparations - metabolism | Bayes Theorem | Female | Aged | Gabapentin - pharmacology | Drugs | Basal ganglia | Amitriptyline | Sensitivity analysis | Gabapentin | Case reports | Central nervous system diseases | Duloxetine | Bayesian analysis | Movement disorders | Index Medicus
Journal Article